SATURDAY MORNING, FEBRUARY 1, 2025
Didactic Sessions Begin @ 8:00 am Level B Ballroom 1 | Cliff Lodge, Snowbird, UT
TUMOR/SKULL BASE
8:00 - 8:15 am |
An Analysis of the Influence of Social Determinants of Health on Treatment and Survival among Adult Patients with High-Grade Glioma in Utah
|
8:15 - 8:20 am | Discussion |
8:20 - 8:35 am |
Assessing Compliance to Reporting Mandates in Glioblastoma-Related Clinical Trials
|
8:35 - 8:40 am | Discussion |
8:40 - 8:55 am |
Liquid Biopsy in Early Detection and Monitoring of CNS Metastases
|
8:55 - 9:00 am | Discussion |
9:00 - 9:15 am |
Does the Crafted Abdominal Fat Grafting Technique Completely Eliminate Risk to Postoperative CSF Leak in Endonasal Pituitary Surgery? Experience in 168 Cases
|
9:15 - 9:20 am | Discussion |
9:20 - 9:40 am |
Targeted Therapy for Glioma...a Breakthrough!
|
9:40 - 9:45 am | Discussion |
9:45 - 10:00 am |
ERK Signaling Promotes Resistance to TRK Kinase Inhibition in NTRK Fusion-Driven Glioma Mouse Models
|
10:00 - 10:05 am | Discussion |
10:05 - 10:20 am |
Eflornithine Improves Survival in Recurrent IDH-Mutant WHO 2021 CNS Grade 3 Astrocytoma
|
10:20 - 10:25 am | Discussion |
10:25 - 10:55 am |
GBM AGILE: A Master Protocol, Adaptive Platform Trial for Late-Stage Glioblastoma Development
|
10:55 - 11:00 am | Discussion |
11:00 am | Adjourn |
SATURDAY AFTERNOON, FEBRUARY 1, 2025
FUNCTIONAL SESSIONS
4:00 - 4:15 pm |
The Nucleosome Remodeling and Deacetylase Complex Underlies Selective Dependency in H3 G34-Mutant Diffuse Hemispheric Glioma
|
4:15 - 4:20 pm | Discussion |
4:20 - 4:35 pm |
Brain Tumor at Barrow
|
4:35 - 4:40 pm | Discussion |
4:40 - 4:55pm |
Aggressive High-Grade NF2 Mutant Meningiomas Downregulate Oncogenic YAP Signaling via the Upregulation of VGLL4 and FAT3/4
|
4:55 - 5:00 pm | Discussion |
5:00 - 5:15 pm |
Surgical Resectability of Spheno-Orbital Meningiomas: Surgical Outcome in 93 Cases and a Proposed Clinically Relevant Anatomical Classification
|
5:15 - 5:20 pm | Discussion |
5:20 - 5:50 pm |
Evolution in the Multi-Disciplinary Management of Netastatic and Primary Spinal Tumors
|
5:50 - 5:55 pm | Discussion |
5:55 - 6:25 pm |
Combining Intraoperative Detection with Therapy of Glioblastoma: A New Paradigm
|
6:25 - 6:30 pm | Discussion |
6:30 pm | Adjourn |
Contact Us
Meeting Coordinator
Lanette Dunbar
Email: lanette.dunbar@hsc.utah.edu
Phone: 801-556-2539
Fax: 801-581-4385
Health Science Center
Bldg 550, 5th Floor
175 N. Medical Drive East
Salt Lake City, UT 84132